Treatment of Intestinal Outlet Obstruction
The treatment of intestinal outlet obstruction should be guided by the location of obstruction, underlying cause, patient's life expectancy, and functional status, with surgical intervention recommended for patients with good functional status and longer life expectancy, while endoscopic stent placement is preferred for those with limited life expectancy.
Evaluation and Diagnosis
Before initiating treatment, proper diagnosis is essential:
- Determine the location of obstruction (esophageal, gastric outlet, small bowel, or colonic)
- Assess for underlying cause (malignant vs. non-malignant)
- Evaluate patient's overall condition and prognosis
- Plain film radiography is usually sufficient to establish bowel obstruction diagnosis, with CT scan recommended if surgical intervention is contemplated 1
Treatment Algorithm Based on Obstruction Location
1. Esophageal Obstruction
For patients with malignant esophageal obstruction:
- If not a candidate for resection: SEMS insertion or brachytherapy (alone or in combination) 1
- If potentially resectable: Avoid routine SEMS placement without multidisciplinary review 1
- When placing SEMS: Use fully covered or partially covered SEMS (not uncovered) 1
- For nutritional concerns: Consider enteral feeding tubes 1
2. Gastric Outlet Obstruction (GOO)
For patients with malignant gastric outlet obstruction:
- If life expectancy >2 months with good functional status: Surgical gastrojejunostomy (preferably laparoscopic approach) 1
- If not a candidate for gastrojejunostomy: Endoscopic placement of an enteral stent 1
- If multiple luminal obstructions or severely impaired gastric motility: Consider venting gastrostomy 1
- For experienced endoscopists: Endoscopic ultrasound-guided gastrojejunostomy is an acceptable alternative 1
3. Malignant Colonic Obstruction
- If candidate for resection: SEMS as "bridge to surgery" to allow one-stage elective resection 1
- If not a candidate for resection: Either SEMS placement or diverting colostomy based on patient's goals and functional status 1
- For proximal (right-sided) obstructions: SEMS is reasonable for both bridge to surgery and palliative care 1
Pharmacologic Management
For symptomatic management of obstruction:
- Opioids for pain control
- Antiemetics (avoid those that increase GI motility in complete obstruction)
- Octreotide: Consider early due to high efficacy (150 mcg SC BID up to 300 BID) 1
- Anticholinergics (scopolamine, hyoscyamine, glycopyrrolate) 1
- Corticosteroids (up to 60 mg/day dexamethasone, discontinue if no improvement in 3-5 days) 1
Additional Supportive Measures
- IV/SC fluids if dehydrated
- Nasogastric tube drainage only if other measures fail to reduce vomiting 1
- Total parenteral nutrition only if expected improvement in quality of life with life expectancy of many months to years 1
Treatment Based on Life Expectancy
- Years: Screen for and treat underlying reversible causes (adhesions, radiation-induced strictures, internal hernias) 1
- Year to months: Assess for malignant causes (tumor mass, carcinomatosis) 1
- Months to weeks: Focus on symptom control (decrease nausea/vomiting, allow eating, decrease pain) 1
- Weeks to days: Consider medical management rather than surgical management 1
Important Considerations and Pitfalls
Avoid routine SEMS placement in potentially resectable esophageal cancer due to high rates of stent migration and potentially lower R0 resection rates 1
Beware of using antiemetics that increase GI motility (like metoclopramide) in complete bowel obstruction, though these may be beneficial in incomplete obstruction 1
Consider patient's prognosis carefully when choosing between stenting and surgical bypass. SEMS placement may be more favorable for patients with shorter life expectancy, while surgical intervention may be preferable for those with longer prognosis 1
For malignant colonic obstruction from extracolonic malignancy, SEMS placement is reasonable but technically more challenging with higher complication rates 1
Multidisciplinary decision-making involving oncologists, surgeons, and endoscopists is essential for optimal management 1